Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services' subsidiary, Optival Health Solutions Private Limited, received a suspension order for the Drug License of its store located at Mahalakshmipuram, Karnataka. The suspension was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-04, and is for a period of three days. The order was received on July 12, 2025, and was issued under Rule 65 of the Drugs and Cosmetics Act, 1940. The company has stated that the potential revenue loss from this suspension is approximately Rs. 0.37 Lakhs, which is negligible relative to overall operations.
The financial impact is minimal at around Rs. 0.37 Lakhs in potential revenue loss for a 3-day suspension of a single store. This is a routine regulatory action with no material effect on the company's overall business or financial position.